Loading…
Cellebrite DI Ltd. is projected to rise to $23.32 by 2027, a +46% move from its current price of $15.94. CLBT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $15.50 | $15.95 | $16.42 | +0.08% |
| Jul 14 | $15.32 | $15.96 | $16.63 | +0.15% |
| Jul 15 | $15.19 | $15.98 | $16.80 | +0.23% |
| Jul 16 | $15.09 | $15.99 | $16.94 | +0.31% |
| Jul 17 | $15.00 | $16.00 | $17.07 | +0.38% |
| Jul 18 | $14.92 | $16.01 | $17.19 | +0.46% |
| Jul 19 | $14.84 | $16.03 | $17.30 | +0.54% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.84 | $16.03 | $17.30 | +0.54% |
| Week 2 | $14.46 | $16.11 | $17.96 | +1.07% |
| Week 3 | $14.18 | $16.20 | $18.50 | +1.61% |
| Week 4 | $13.97 | $16.28 | $18.98 | +2.16% |
| Week 5 | $13.79 | $16.37 | $19.43 | +2.70% |
| Week 6 | $13.64 | $16.46 | $19.86 | +3.25% |
| Week 7 | $13.51 | $16.55 | $20.27 | +3.81% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cellebrite DI Ltd. (CLBT) is a technology company that develops software and services for legally sanctioned investigations across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency.
It is headquartered in Petah Tikva, Israel. The offerings include Inseyets, Guardian Forensics, Guardian Collaborate, Guardian Investigate, Pathfinder, Corellium Falcon, and Corellium Viper, along with professional services and advanced services.
Cellebrite DI Ltd. is a technology company listed with a current price of $16.61 and a market cap of $4.14B. It ranks 1516 in market capitalization. The current price and fundamental position place it within a broad technology services category focused on digital forensics and investigations.
The projected price path shows a rising trajectory in the years ahead, with sentiment turning bullish after 2026 in the provided forecasts.
A major floor 32.2% below — a decisive break under it would weaken the trend.
The nearest floor, 22.1% below — buyers have tended to step in here.
The nearest ceiling, 4.2% above — a clean break opens room to run.
A major ceiling 20.3% above — clearing it would confirm fresh momentum.
Key CLBT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLBT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $16.35 | Sell | $16.02 | Sell |
| MA 10 | $15.54 | Buy | $15.50 | Buy |
| MA 20 | $14.14 | Buy | $14.75 | Buy |
| MA 50 | $13.73 | Buy | $14.08 | Buy |
| MA 100 | $13.68 | Buy | $14.21 | Buy |
| MA 200 | $15.56 | Buy | $14.95 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.09 | Neutral |
| Stoch RSI (14) | 72.62 | Neutral |
| CCI (20) | 83.43 | Neutral |
| Williams %R (14) | -15.99 | Info |
| MACD (12,26,9) | 0.28 | Buy |
| ROC (12) | 25.12 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 84.01 | Sell |
| TRIX (15) | 0.52 | Buy |
| Awesome (5,34) | 2.38 | Buy |
| Ultimate (7,14,28) | 73.16 | Sell |
| Momentum (10) | 3.31 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 16.60 | Sell |
| ADX (14) | 23.59 | Buy |
| ATR (14) | 0.37 | Info |
The 30 day technical picture shows bullish sentiment with RSI14 at 70. The near term moving averages are SMA50 at $13.44 and SMA200 at $15.59. The stock has support at $12.42 and resistance at $16.61. The 30 day range is $13.43 to $20.54, indicating potential upside beyond the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.03 | $15.94 | $23.51 | 0% | Neutral | |
| $18.46 | $23.32 | $31.24 | +46% | Bullish | |
| $22.69 | $29.53 | $41.11 | +85% | Bullish | |
| $23.17 | $30.91 | $44.37 | +94% | Bullish | |
| $23.38 | $31.88 | $46.94 | +100% | Bullish | |
| $26.92 | $37.45 | $56.37 | +135% | Bullish | |
| $30.35 | $43.01 | $66.05 | +170% | Bullish | |
| $36.86 | $53.16 | $83.12 | +233% | Bullish | |
| $40.72 | $59.71 | $94.92 | +275% | Bullish | |
| $41.63 | $62.02 | $100.13 | +289% | Bullish | |
| $65.40 | $104.77 | $180.38 | +557% | Bullish | |
| $104.46 | $189.78 | $358.78 | +10.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.03 | $15.94 | $19.73 | +0.00% |
| August 2026 | $14.56 | $17.22 | $20.92 | +8.01% |
| September 2026 | $14.35 | $17.09 | $21.01 | -0.75% |
| October 2026 | $14.41 | $17.27 | $21.44 | +1.07% |
| November 2026 | $15.07 | $18.17 | $22.75 | +5.20% |
| December 2026 | $15.39 | $18.64 | $23.51 | +2.58% |
Click any year to see its month-by-month CLBT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CLBT price prediction for 2026 points to an average of $15.94 (low $11.03, high $23.51) — a potential gain of 0% on today's $15.94. Price action looks broadly range-bound.
In 2027, CLBT is projected to trade between $18.46 and $31.24, averaging $23.32 — a potential gain of +46% from today's $15.94. That is up +46% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Cellebrite DI Ltd.'s 2028 outlook centres on $29.53, within a $22.69 to $41.11 range. That is up +27% on the projected 2027 average. That marks a +85% change versus current levels. Momentum favours further upside here.
By 2029, CLBT could reach as high as $44.37, with a base case around $30.91 and support toward $23.17 — roughly +94% from $15.94. Buyers look set to stay in control over this stretch.
Expect CLBT to range from $23.38 to $46.94 through 2030. The $31.88 average target implies a +100% move from current prices. That is up +3% on the projected 2029 average. Momentum favours further upside here.
The CLBT price prediction for 2031 points to an average of $37.45 (low $26.92, high $56.37) — a potential gain of +135% on today's $15.94. Buyers look set to stay in control over this stretch.
In 2032, CLBT is projected to trade between $30.35 and $66.05, averaging $43.01 — a potential gain of +170% from today's $15.94. That is up +15% on the projected 2031 average. Momentum favours further upside here.
Cellebrite DI Ltd.'s 2033 outlook centres on $53.16, within a $36.86 to $83.12 range. That is up +24% on the projected 2032 average. That marks a +233% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, CLBT could reach as high as $94.92, with a base case around $59.71 and support toward $40.72 — roughly +275% from $15.94. Momentum favours further upside here.
Expect CLBT to range from $41.63 to $100.13 through 2035. The $62.02 average target implies a +289% move from current prices. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The CLBT price prediction for 2040 points to an average of $104.77 (low $65.40, high $180.38) — a potential gain of +557% on today's $15.94. Momentum favours further upside here.
In 2050, CLBT is projected to trade between $104.46 and $358.78, averaging $189.78 — a potential gain of +10.9x from today's $15.94. That is up +81% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CLBT today (≈ 62.735257 CLBT) could be worth
$11,905.97
+$10,905.97 (+1091%) by 2050 · US Dollar
Based on the average projected CLBT price of $189.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLBTwould be worth at today's price.
$1,000 invested in CLBT on Jul 10, 2025 (≈ 67.79661 CLBT) would be worth
$1,080.68
+$80.68 (+8.1%) today · 1.08× · US Dollar
Based on a CLBT entry price of $14.75 vs. today's $15.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.65 | $1,018.53 | +1.9% |
| 1 month ago | $12.99 | $1,227.1 | +22.7% |
| 3 months ago | $11.03 | $1,445.15 | +44.5% |
| 6 months ago | $18.05 | $883.1 | -11.7% |
| 1 year ago | $14.75 | $1,080.68 | +8.1% |
| All time (5.0y) ago | $9.95 | $1,601.21 | +60.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLBT forecast.
Our base-case forecast reaches $32.00 around 2031.
Implied market cap at $32.00: $7.98B
The multi year forecast presents a path of rising averages and significant upside. In 2026 the avg price is $16.61 with a min of $11.03 and a max of $25.40 and a neutral sentiment. The forecast turns bullish starting in 2027 with 2027 avg $25.65 and 2028 avg $33.24, rising further to 2030 avg $36.18 with an ROI of 117.8 and bullish sentiment.
By 2040 the avg reaches $135.21 with an ROI of 714 and bullish sentiment, and by 2050 the avg is $251.39 with an ROI of 1413.5, remaining bullish. Key year anchors include 2030 at avg 36.18 and 117.8 ROI, 2040 at avg 135.21 and 714 ROI, and 2050 at avg 251.39 and 1413.5 ROI. These figures are estimates and not guarantees, and are subject to the usual uncertainties of market forecasting.
Tap a question to reveal the answer.
2030 avg $36.18; min $25.98; max $54.54; ROI 117.8; sentiment BULLISH.
The forecast shows sentiment turning bullish from 2027 onward, with increasing averages such as 2027 avg $25.65, 2028 avg $33.24, 2030 avg $36.18, and 2050 avg $251.39, yielding ROI up to 1413.5% by 2050.
Yes. The forecast max prices show above 100 in several years, including 2033 max $104.04, 2034 max $120.29, 2035 max $125.99, and later years such as 2040 max $241.28 and 2050 max $495.70.
Current price $16.61; Market cap $4.14B.
RSI14 is 70; 30 day range is $13.43 to $20.54; SMA50 is $13.44; SMA200 is $15.59; support is $12.42 and resistance is $16.61.
Cellebrite DI Ltd. Community Discussion
0Share your Cellebrite DI Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.